Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Stratton

Showing results (361-370 of 525) with videos related to

Pageof 53
Sort By:
Cancer Biology & Therapy|September 14, 2006
Recurrent KRAS codon 146 mutations in human colorectal cancerSarah Edkins, Sarah O'Meara, Adrian Parker, et al.
Genes, Chromosomes & Cancer|August 21, 2010
Use of cancer-specific genomic rearrangements to quantify disease burden in plasma from patients with solid tumorsDavid J McBride, Arto K Orpana, Christos Sotiriou, et al.
Genome Research|February 8, 2006
Decoding the fine-scale structure of a breast cancer genome and transcriptomeStanislav Volik, Benjamin J Raphael, Guiqing Huang, et al.
Nature Communications|December 19, 2018
Author Correction: Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressorsJiqiu Cheng, Jonas Demeulemeester, David C Wedge, et al.
Nature Communications|November 2, 2017
Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressorsJiqiu Cheng, Jonas Demeulemeester, David C Wedge, et al.
Nature Communications|January 30, 2019
Author Correction: Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressorsJiqiu Cheng, Jonas Demeulemeester, David C Wedge, et al.
Cancer Research|September 2, 2000
The frequency of germ-line mutations in the breast cancer predisposition genes BRCA1 and BRCA2 in familial prostate cancer. The Cancer Research Campaign/British Prostate Group United Kingdom Familial Prostate Cancer Study CollaboratorsS A Gayther, K A de Foy, P Harrington, et al.
Human Genetics|December 22, 1998
Confirmation of FWT1 as a Wilms' tumour susceptibility gene and phenotypic characteristics of Wilms' tumour attributable to FWT1N Rahman, F Abidi, D Ford, et al.
Nature|February 19, 2010
Signatures of mutation and selection in the cancer genomeGraham R Bignell, Chris D Greenman, Helen Davies, et al.
Nature Genetics|October 1, 2021
Increased somatic mutation burdens in normal human cells due to defective DNA polymerasesPhilip S Robinson, Tim H H Coorens, Claire Palles, et al.
Pageof 53

Showing results (361-370 of 525) with videos related to

Sort By:
Pageof 53
Cancer Biology & Therapy|September 14, 2006
Recurrent KRAS codon 146 mutations in human colorectal cancerSarah Edkins, Sarah O'Meara, Adrian Parker, et al.
Genes, Chromosomes & Cancer|August 21, 2010
Use of cancer-specific genomic rearrangements to quantify disease burden in plasma from patients with solid tumorsDavid J McBride, Arto K Orpana, Christos Sotiriou, et al.
Genome Research|February 8, 2006
Decoding the fine-scale structure of a breast cancer genome and transcriptomeStanislav Volik, Benjamin J Raphael, Guiqing Huang, et al.
Nature Communications|December 19, 2018
Author Correction: Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressorsJiqiu Cheng, Jonas Demeulemeester, David C Wedge, et al.
Nature Communications|November 2, 2017
Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressorsJiqiu Cheng, Jonas Demeulemeester, David C Wedge, et al.
Nature Communications|January 30, 2019
Author Correction: Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressorsJiqiu Cheng, Jonas Demeulemeester, David C Wedge, et al.
Cancer Research|September 2, 2000
The frequency of germ-line mutations in the breast cancer predisposition genes BRCA1 and BRCA2 in familial prostate cancer. The Cancer Research Campaign/British Prostate Group United Kingdom Familial Prostate Cancer Study CollaboratorsS A Gayther, K A de Foy, P Harrington, et al.
Human Genetics|December 22, 1998
Confirmation of FWT1 as a Wilms' tumour susceptibility gene and phenotypic characteristics of Wilms' tumour attributable to FWT1N Rahman, F Abidi, D Ford, et al.
Nature|February 19, 2010
Signatures of mutation and selection in the cancer genomeGraham R Bignell, Chris D Greenman, Helen Davies, et al.
Nature Genetics|October 1, 2021
Increased somatic mutation burdens in normal human cells due to defective DNA polymerasesPhilip S Robinson, Tim H H Coorens, Claire Palles, et al.
Pageof 53